» Articles » PMID: 17409386

The Rab5 Activator ALS2/alsin Acts As a Novel Rac1 Effector Through Rac1-activated Endocytosis

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2007 Apr 6
PMID 17409386
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the ALS2 gene cause a number of recessive motor neuron diseases, indicating that the ALS2 protein (ALS2/alsin) is vital for motor neurons. ALS2 acts as a guanine nucleotide exchange factor (GEF) for Rab5 (Rab5GEF) and is involved in endosome dynamics. However, the spatiotemporal regulation of the ALS2-mediated Rab5 activation is unclear. Here we identified an upstream activator for ALS2 and showed a functional significance of the ALS2 activation in endosome dynamics. ALS2 preferentially interacts with activated Rac1. In the cells activated Rac1 recruits cytoplasmic ALS2 to membrane ruffles and subsequently to nascent macropinosomes via Rac1-activated macropinocytosis. At later endocytic stages macropinosomal ALS2 augments fusion of the ALS2-localized macropinosomes with the transferrin-positive endosomes, depending on the ALS2-associated Rab5GEF activity. These results indicate that Rac1 promotes the ALS2 membranous localization, thereby rendering ALS2 active via Rac1-activated endocytosis. Thus, ALS2 is a novel Rac1 effector and is involved in Rac1-activated macropinocytosis. All together, loss of ALS2 may perturb macropinocytosis and/or the following membrane trafficking, which gives rise to neuronal dysfunction in the ALS2-linked motor neuron diseases.

Citing Articles

Spastin and alsin protein interactome analyses begin to reveal key canonical pathways and suggest novel druggable targets.

Helmold B, Ahrens A, Fitzgerald Z, Ozdinler P Neural Regen Res. 2024; 20(3):725-739.

PMID: 38886938 PMC: 11433914. DOI: 10.4103/NRR.NRR-D-23-02068.


The endolysosomal pathway and ALS/FTD.

Todd T, Shao W, Zhang Y, Petrucelli L Trends Neurosci. 2023; 46(12):1025-1041.

PMID: 37827960 PMC: 10841821. DOI: 10.1016/j.tins.2023.09.004.


Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2.

Kim S, Nichols K, Anderson E, Liu Y, Ramesh N, Jia W Elife. 2023; 12.

PMID: 37039476 PMC: 10147378. DOI: 10.7554/eLife.84382.


Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies.

Rossi Sebastiano M, Ermondi G, Sato K, Otomo A, Hadano S, Caron G Molecules. 2022; 27(20).

PMID: 36296656 PMC: 9609931. DOI: 10.3390/molecules27207063.


Amyloid Beta Is Internalized Macropinocytosis, an HSPG- and Lipid Raft-Dependent and Rac1-Mediated Process.

Nazere K, Takahashi T, Hara N, Muguruma K, Nakamori M, Yamazaki Y Front Mol Neurosci. 2022; 15:804702.

PMID: 36187354 PMC: 9524458. DOI: 10.3389/fnmol.2022.804702.